Trexquant Investment 13F: Cuts CL Stake by $2.5M

Trexquant Trims Colgate-Palmolive Holdings

Trexquant Investment reduced its position in Colgate-Palmolive Company (NYSE: CL) during the quarter ended May 15, 2026, according to a Form 13F filed with the U.S. Securities and Exchange Commission. The filing reflects holdings as of that reporting date and may not represent the fund's current position today. The fund trimmed its holdings by an 8.2% margin, shedding 26,892 shares from its previous count.

Position Details and Share Reduction

Before the adjustment, Trexquant held 327,675 shares of the consumer products maker. Following the sale, the fund's holdings dropped to 300,783 shares. Based on a cost basis of $87.23 per share, the remaining stake carried an estimated value of $27.58 million at the time of the report. This filing follows several other portfolio adjustments by the firm, including a recent reduction in AbbVie shares and a new stake in Canadian National Railway.

Colgate-Palmolive Stock Price Action

Colgate-Palmolive shares trade around $91.68 on the New York Stock Exchange. The stock sits between a 52-week low of $74.55 and a 52-week high of $99.33. Its moving averages show the stock holding near $89.13 for the 50-day line and $88.92 for the 200-day line. The company carries a market capitalization of roughly $73.87 billion and a forward P/E ratio of 22.68.

Recent Earnings Performance

For its recent financial reporting period, Colgate-Palmolive posted annual revenue of $21.05 billion with a revenue growth rate of 4.9%. The company generated earnings of $2.54 per share. Profitability metrics show a net margin of 9.68% and a return on equity of 2.67%. The consumer goods company is scheduled to release its next batch of earnings data on October 30, 2026.

Dividend Profile

Income-focused investors track the company's dividend program closely. Colgate-Palmolive provides a dividend yield of 2.29%. The payout is backed by a dividend payout ratio of 82.28%, showing how much of its earnings the firm returns to shareholders through regular distributions.

Wall Street Analyst Views

Several research firms have updated their outlooks on Colgate-Palmolive shares in recent months. On October 5, 2026, Wells Fargo maintained an Equal-Weight rating while adjusting its price target to $90.00 from $95.00. Earlier, on September 21, 2026, Piper Sandler maintained an Overweight rating and set a $95.00 price target. RBC Capital reiterated its Outperform rating on September 8, 2026, with a $104.00 target. Additional updates came on August 3, 2026, when UBS maintained a Buy rating and raised its target to $109.00, TD Cowen maintained a Hold rating with a $90.00 target, JP Morgan kept an Overweight rating with a $103.00 target, and Evercore ISI Group maintained an Outperform rating with a $101.00 target. Overall, 20 analysts cover the stock, producing a consensus recommendation of buy and a mean price target of $98.10.

Understanding Colgate-Palmolive

Colgate-Palmolive Company manufactures and sells household and personal care items alongside pet nutrition products. Operating through segments like Oral, Personal and Home Care and Pet Nutrition, the New York-based firm markets well-known brands such as Colgate, Palmolive, Hill's Science Diet, Murphy, and Softsoap to traditional retailers, e-commerce platforms, and dental professionals. Founded in 1806, the company continues to supply everyday consumer goods globally.

Looking Ahead at Institutional Holdings

Investors monitoring Trexquant Investment will need to wait for subsequent quarterly disclosures to see if the fund continues trimming or stabilizes its position in Colgate-Palmolive. Because 13F filings look backward, the reported figures capture only a snapshot in time. Observers can also watch upcoming earnings reports and analyst revisions for further direction on the stock.